In vitro studies of the immunomodulatory effects of statins alone and in combination with immunosuppressive drugs

European Journal of Inflammation

Volumn 9, Issue 2, 2011, Pages 117-124

  Guillen D ^a,c   Millan O ^a,b   Brunet, Mercè ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cytokine production; Immunomodulatory effect; Immunosuppressive drugs; Lymphocyte proliferation; Statins

Indexed keywords

ATORVASTATIN; CYTOKINE; EVEROLIMUS; FLUINDOSTATIN; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; SIMVASTATIN; TACROLIMUS;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 81855161230     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900205     Document Type: Article

References (25)

1. Jacobson JR. Statins in endothelial signaling and activation. Antioxid Redox Signal 2009; 11:811-21.
2. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006; 6:358-70.
3. Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 2005; 15:202-206. (Pubitemid 41338006)
4. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008; 14:37-44.
5. Shimada K, Park JK, Daida H. T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents? Eur Heart J 2006; 27:2916-18. (Pubitemid 44950427)
6. Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, Sakata R. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006; 36:201-10. (Pubitemid 46529472)
7. Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol 2007; 28:88-98. (Pubitemid 46178495)
8. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6:1399-402. (Pubitemid 32001026)
9. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7:687-92. (Pubitemid 32588024)
10. Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med 2006; 203:401-12. (Pubitemid 43290849)
11. Nie C, Yang D, Liu G, Dong D, Ma Z, Fu H, Zhao Z, Zhiyong S. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation. Eur J Pharmacol 2009; 602:168-75.
12. Bessler H, Salman H, Bergman M, Straussberg R, Djaldetti M. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells. Clin Immunol 2005; 117:73-77. (Pubitemid 41725472)
13. Link A, Ayadhi T, Böhm M, Nickenig G. Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. Eur Heart J 2006; 27:2945-55. (Pubitemid 44950437)
14. Takahashi HK, Iwagaki H, Yagi T, Kanke T, Liu K, Yoshino T, Tanaka N, Nishibori M. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction. Clin Immunol 2007; 123:324-32. (Pubitemid 46818125)
15. Guillen D, Cofan F, Ros E, Millan O, Cofan M, Rimola A, Brunet M. Determination of atorvastatin and its metabolite ortho-hydroxyatorvastatin in human plasma by on-line anion-exchange solid-phase extraction and liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2009; 394:1687-96.
16. Borek-Dohalsky V, Huclova J, Barrett B, Nemec B, Ulc I, Jelinek I. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma - pharmacokinetic study. Anal Bioanal Chem 2006; 386:275-85. (Pubitemid 44327024)
17. Nirogi R, Kandikere VN, Shrivastava W, Mudigonda K, Datla PV. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of fluvastatin in human plasma: validation and its application to pharmacokinetic studies. Rapid Commun Mass Spectrom 2006; 20:1225-30.
18. Yang H, Feng Y, Luan Y. Determination of Simvastatin in human plasma by liquid chromatography-mass spectrometry. J Chromatogr B 2003; 785:369-75. (Pubitemid 36131091)
19. Dambrin C, Klupp J, Morris RE. Pharmacodynamics of immunosuppressive drugs. Current Opinion in Immunology 2000; 12:557-62.
20. Brunet M, Campistol JM, Diekmann F, Guillen D, Millan O. T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy. Mol Diagn Ther 2007; 11:247-56. (Pubitemid 47359077)
21. H. Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol 2003; 57:298-309.
22. Piekoszewski W, Chow FS, Jusko WJ. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. Drug Metab Dispos 1993; 21:690-8. (Pubitemid 23221766)
23. Barten MJ, Streit F, Boeger M, et al. Synergistic effects of sirolimus with cyclosporin and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. Transplantation 2004; 77:1154-62. (Pubitemid 38580289)
24. Youssef S, Stüve O, Patarroyo JC, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420:78-84. (Pubitemid 35291443)
25. Takahashi HK, Mori S, Iwagaki H, Yoshimo T, Tanaka N, Nishibori M. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells. Clin Immunol 2005; 116:211-16. (Pubitemid 41112724)